Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatment.
Harriman
G
G
Immunology Clinical Research, Centocor, Inc, 200 Great Valley Parkway, Malvern, PA 19355-1307, USA.
Harper
L K
LK
Schaible
T F
TF
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab